Rod and Cone Dystrophy is a progressive, hereditary retinal disorder, and as with most genetic retinal conditions, treatment conventionally centers on low-vision support, UV protection, and monitoring how the disease progresses rather than reversing it. India has become a preferred choice for **Rod and Cone Dystrophy treatment for patients from Mexico**, though a complete cure for this genetic condition remains an ongoing pursuit within global medicine.
Within a wider Rod and Cone Dystrophy treatment strategy, stem cell-based therapy is seen as an area of active clinical interest for patients whose photoreceptor cells are breaking down over time. This treatment path is explored for its potential to support the rod and cone cells that remain functional, giving patients an added option to weigh alongside standard low-vision care.
Mesenchymal Stem Cell Effectivity Within Rod and Cone Dystrophy TreatmentAs part of a structured Rod and Cone Dystrophy treatment plan, Mesenchymal stem cell injections via the Retro-bulbar route have proven to be a dependable method, typically needing one or two sessions. This technique has built a favorable record supporting the regenerative response of retinal cells impacted by progressive photoreceptor loss, with relevance spanning photoreceptor cells, the retinal pigment epithelium, and macular cells.
Patients in Mexico managing this inherited condition are welcome to connect with the Eye Stem Cell Center, which brings more than 12 years of focused experience with genetic retinal dystrophies. Our team carries out a detailed review — including ERG and OCT findings — before advising on the way forward.
Eye Stem Cell Center is one of the most trusted providers of **Rod and Cone Dystrophy treatment in Mexico.

